Genetic Link to IBD: UQ Mater Discovery in Family Study | AcademicJobs
Discover how Brisbane's Mater Research and UQ identified a rare OTUD3 genetic mutation causing ulcerative colitis in a family study, paving the way for new IBD treatments.
No reviews yet. Be the first to rate Rabina!
Dr Rabina Giri is a postdoctoral researcher in the Inflammatory Bowel Disease group at Mater Research, affiliated with The University of Queensland. She completed her Doctor of Philosophy in Microbiology at the Mater Research Institute – The University of Queensland in 2024. Her doctoral work established a bioactive discovery pipeline to examine interactions between the gut immune system and microbial communities through cell-based assays and pre-clinical models.
Dr Giri’s research investigates how the gut microbiome modulates immune responses in inflammatory bowel disease and evaluates microbial-derived small molecules as potential therapeutics. Her contributions include the identification and characterization of a novel gene associated with ulcerative colitis via exome sequencing and the development of a spontaneous colitis animal model. This work has supported a provisional patent for a small molecule treatment for IBD and contributed to the formation of Micromune Therapeutics. She holds an honorary fellow position in the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland and continues her investigations as a postdoctoral researcher.
Discover how Brisbane's Mater Research and UQ identified a rare OTUD3 genetic mutation causing ulcerative colitis in a family study, paving the way for new IBD treatments.